Chimeric Virus-like Particles of the Human Papillomavirus Type 16 (HPV 16) as a Prophylactic and Therapeutic Vaccine
- 1 July 1999
- journal article
- review article
- Published by Elsevier in Archives of Medical Research
- Vol. 30 (4) , 269-274
- https://doi.org/10.1016/s0188-0128(99)00026-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Oral Somatic Transgene Vaccination Using Attenuated S. typhimuriumCell, 1997
- Epidemiologic Determinants of Seroreactivity to Human Papillomavirus (HPV) Type 16 Virus-Like Particles in Cervical HPV-16 DNA--Positive and --Negative WomenThe Journal of Infectious Diseases, 1996
- Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice.Proceedings of the National Academy of Sciences, 1996
- Virus-like Particles of Bovine Papillomavirus Type 4 in Prophylactic and Therapeutic ImmunizationVirology, 1996
- Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas.Proceedings of the National Academy of Sciences, 1995
- Transgenic plants as vaccine production systemsTrends in Biotechnology, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Oral Immunization with a Recombinant Bacterial Antigen Produced in Transgenic PlantsScience, 1995
- Immunological Events in Regressing Genital WartsAmerican Journal of Clinical Pathology, 1994
- Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat wartsCancer, 1986